Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells

Nature Immunology

Volumn 14, Issue 8, 2013, Pages 867-875

  Nechanitzky, Robert ^a   Akbas, Duygu ^a   Scherer, Stefanie ^a   Györy, Ildiko ^a   Hoyler, Thomas ^b   Ramamoorthy, Senthilkumar ^a   Diefenbach, Andreas ^b   Grosschedl, Rudolf ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; INHIBITOR OF DIFFERENTIATION 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR EBF1; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL FATE; CELL LINEAGE; CONTROLLED STUDY; GENE DELETION; GENE REPRESSION; IN VITRO STUDY; IN VIVO STUDY; LAMINA PROPRIA; LYMPHOID CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THYMOCYTE; TRANSCRIPTION REGULATION;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; DNA; GENE EXPRESSION REGULATION; LYMPHOPOIESIS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANS-ACTIVATORS; V(D)J RECOMBINATION;

EID: 84880780575     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2641     Document Type: Article

References (50)

1. Adolfsson, J. et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295-306 (2005).
2. Mercer, E.M. et al. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35, 413-425 (2011).
3. Ng, S.Y., Yoshida, T., Zhang, J. & Georgopoulos, K. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 30, 493-507 (2009).
4. Ichii, M. et al. Functional diversity of stem and progenitor cells with B-lymphopoietic potential. Immunol. Rev. 237, 10-21 (2010).
5. Klose, C.S., Hoyler, T., Kiss, E.A., Tanriver, Y. & Diefenbach, A. Transcriptional control of innate lymphocyte fate decisions. Curr. Opin. Immunol. 24, 290-296 (2012).
6. Igarashi, H., Gregory, S.C., Yokota, T., Sakaguchi, N. & Kincade, P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117-130 (2002).
7. Inlay, M.A. et al. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev. 23, 2376-2381 (2009).
8. Mansson, R. et al. Single-cell analysis of the common lymphoid progenitor compartment reveals functional and molecular heterogeneity. Blood 115, 2601-2609 (2010).
9. Lin, Y.C. et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol. 11, 635-643 (2010).
10. Mandel, E.M. & Grosschedl, R. Transcription control of early B cell differentiation. Curr. Opin. Immunol. 22, 161-167 (2010).
11. Mansson, R. et al. Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate. Proc. Natl. Acad. Sci. USA 109, 21028-21033 (2012).
12. Medina, K.L. et al. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7, 607-617 (2004).
13. Reynaud, D. et al. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 9, 927-936 (2008).
14. Seet, C.S., Brumbaugh, R.L. & Kee, B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689-1700 (2004).
15. Zandi, S. et al. Single-cell analysis of early B-lymphocyte development suggests independent regulation of lineage specification and commitment in vivo. Proc. Natl. Acad. Sci. USA 109, 15871-15876 (2012).
16. Cobaleda, C. & Busslinger, M. Developmental plasticity of lymphocytes. Curr. Opin. Immunol. 20, 139-148 (2008).
17. Nutt, S.L. & Kee, B.L. The transcriptional regulation of B cell lineage commitment. Immunity 26, 715-725 (2007).
18. Rothenberg, E.V. T cell lineage commitment: Identity and renunciation. J. Immunol. 186, 6649-6655 (2011).
19. Welinder, E., Ahsberg, J. & Sigvardsson, M. B-lymphocyte commitment: Identifying the point of no return. Semin. Immunol. 23, 335-340 (2011).
20. Mikkola, I., Heavey, B., Horcher, M. & Busslinger, M. Reversion of B cell commitment upon loss of Pax5 expression. Science 297, 110-113 (2002).
21. Nutt, S.L., Heavey, B., Rolink, A.G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556-562 (1999).
22. Rolink, A.G., Nutt, S.L., Melchers, F. & Busslinger, M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401, 603-606 (1999).
23. Cobaleda, C., Jochum, W. & Busslinger, M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449, 473-477 (2007).
24. Delogu, A. et al. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24, 269-281 (2006).
25. McManus, S. et al. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J. 30, 2388-2404 (2011).
26. Decker, T. et al. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity 30, 508-520 (2009).
27. Roessler, S. et al. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol. Cell Biol. 27, 579-594 (2007).
28. Pongubala, J.M. et al. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat. Immunol. 9, 203-215 (2008).
29. Thal, M.A. et al. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc. Natl. Acad. Sci. USA 106, 552-557 (2009).
30. Treiber, T. et al. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription-independent poising of chromatin. Immunity 32, 714-725 (2010).
31. Lukin, K. et al. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes. Eur. J. Immunol. 41, 1787-1793 (2011).
32. Györy, I. et al. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev. 26, 668-682 (2012).
33. Vilagos, B. et al. Essential role of EBF1 in the generation and function of distinct mature B cell types. J. Exp. Med. 209, 775-792 (2012).
34. Fuxa, M. et al. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18, 411-422 (2004).
35. Spits, H. et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013).
36. Heng, T.S. & Painter, M.W. The Immunological Genome Project: Networks of gene expression in immune cells. Nat. Immunol. 9, 1091-1094 (2008).
37. Dengler, H.S. et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat. Immunol. 9, 1388-1398 (2008).
38. Kieslinger, M., Hiechinger, S., Dobreva, G., Consalez, G.G. & Grosschedl, R. Early B cell factor 2 regulates hematopoietic stem cell homeostasis in a cell-nonautonomous manner. Cell Stem Cell 7, 496-507 (2010).
39. Bussmann, L.H. et al. A robust and highly efficient immune cell reprogramming system. Cell Stem Cell 5, 554-566 (2009).
40. Di Tullio, A. et al. CCAAT/enhancer binding protein alpha (C/EBPα)-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation. Proc. Natl. Acad. Sci. USA 108, 17016-17021 (2011).
41. Germar, K. et al. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc. Natl. Acad. Sci. USA 108, 20060-20065 (2011).
42. Weber, B.N. et al. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476, 63-68 (2011).
43. García-Ojeda, M.E. et al. GATA-3 promotes T-cell specification by repressing B-cell potential in pro-T cells in mice. Blood 121, 1749-1759 (2013).
44. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634-648 (2012).
45. Moro, K. et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463, 540-544 (2010).
46. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999).
47. Sambandam, A. et al. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat. Immunol. 6, 663-670 (2005).
48. Yamamoto, N. et al. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J. Biol. Chem. 276, 45031-45040 (2001).
49. Rothenberg, E.V. Transcriptional drivers of the T-cell lineage program. Curr. Opin. Immunol. 24, 132-138 (2012).
50. Hobeika, E. et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 103, 13789-13794 (2006).